Wallingford, CT, United States of America

Marc A Bruce


Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1996-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Marc A. Bruce - Pioneering Inventor from Wallingford, CT

Introduction: Marc A. Bruce, a prolific inventor hailing from Wallingford, CT, has made significant contributions in the field of pharmaceuticals. With a total of 8 patents to his name, Bruce has consistently showcased his innovative prowess in developing cutting-edge solutions.

Latest Patents: Among his latest patents are groundbreaking inventions such as "Alkylamine Derivatives of Dihydropyridine NPY Antagonists" and "NPY Antagonists: Spiroisoquinolinone Derivatives." These patents highlight Bruce's expertise in the development of novel pharmaceutical compounds with potential therapeutic applications.

Career Highlights: Marc A. Bruce is affiliated with Bristol-Myers Squibb Company, a renowned pharmaceutical giant. His association with this esteemed organization has provided him with a platform to further his research and bring his inventive ideas to fruition. Bruce's portfolio of patents underscores his ability to innovate in a competitive industry.

Collaborations: Throughout his career, Marc A. Bruce has collaborated with esteemed colleagues such as Graham S. Poindexter and Graham Johnson. These partnerships have not only enriched his research endeavors but have also led to the creation of impactful inventions that have the potential to revolutionize the pharmaceutical landscape.

Conclusion: In conclusion, Marc A. Bruce stands out as a visionary inventor who continues to push the boundaries of innovation in the pharmaceutical sector. His impressive track record of patents and collaborations solidify his position as a trailblazer in the field. We look forward to witnessing more groundbreaking inventions from this talented individual in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…